PMC:7417201 / 17776-19287 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T29","span":{"begin":554,"end":558},"obj":"Body_part"},{"id":"T30","span":{"begin":810,"end":814},"obj":"Body_part"}],"attributes":[{"id":"A29","pred":"fma_id","subj":"T29","obj":"http://purl.org/sig/ont/fma/fma9712"},{"id":"A30","pred":"fma_id","subj":"T30","obj":"http://purl.org/sig/ont/fma/fma9712"}],"text":"The lesson we learned from this global experience may be useful to improve nuclear medicine laboratories’ daily activities. Such implementation should have been put into practice as standard protocol rather than only during potential new emergencies. This is the only way to assure high-quality healthcare performances in terms of numbers and therapeutic strategies regardless specific contingencies without sacrificing medical assistance in favor of emergency needs. Protection of healthcare personnel, with personal protective equipment use and strict hand and laboratory hygiene, should be always recommended. To minimize contact, all information regarding the performing test, clinical history data, and consent to undertake the test should be provided prior to the patients’ on-site arrival. On the other hand, patient’s compliance should be always assured with a brief and safe interview before test. Regarding the choice of imaging protocol during the pandemic, this aspect should take into account only the diagnostic and prognostic evidences provided by literature as regards to the maximum benefit of patients from the type of test performed preferring 1-day-pharmacological stress-first SPECT-MPI protocols to optimize not only radioactive dose exposure but also the time of patient staying in hospital facilities. Patient selection for SPECT-MPI should be based on clinical judgment on expected benefit to guide management, on the urgency of the test, and in discussion with the referring clinician."}

{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T31","span":{"begin":554,"end":558},"obj":"Body_part"},{"id":"T32","span":{"begin":810,"end":814},"obj":"Body_part"}],"attributes":[{"id":"A31","pred":"uberon_id","subj":"T31","obj":"http://purl.obolibrary.org/obo/UBERON_0002398"},{"id":"A32","pred":"uberon_id","subj":"T32","obj":"http://purl.obolibrary.org/obo/UBERON_0002398"}],"text":"The lesson we learned from this global experience may be useful to improve nuclear medicine laboratories’ daily activities. Such implementation should have been put into practice as standard protocol rather than only during potential new emergencies. This is the only way to assure high-quality healthcare performances in terms of numbers and therapeutic strategies regardless specific contingencies without sacrificing medical assistance in favor of emergency needs. Protection of healthcare personnel, with personal protective equipment use and strict hand and laboratory hygiene, should be always recommended. To minimize contact, all information regarding the performing test, clinical history data, and consent to undertake the test should be provided prior to the patients’ on-site arrival. On the other hand, patient’s compliance should be always assured with a brief and safe interview before test. Regarding the choice of imaging protocol during the pandemic, this aspect should take into account only the diagnostic and prognostic evidences provided by literature as regards to the maximum benefit of patients from the type of test performed preferring 1-day-pharmacological stress-first SPECT-MPI protocols to optimize not only radioactive dose exposure but also the time of patient staying in hospital facilities. Patient selection for SPECT-MPI should be based on clinical judgment on expected benefit to guide management, on the urgency of the test, and in discussion with the referring clinician."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T153","span":{"begin":112,"end":122},"obj":"http://purl.obolibrary.org/obo/CLO_0001658"},{"id":"T154","span":{"begin":675,"end":679},"obj":"http://purl.obolibrary.org/obo/UBERON_0000473"},{"id":"T155","span":{"begin":733,"end":737},"obj":"http://purl.obolibrary.org/obo/UBERON_0000473"},{"id":"T156","span":{"begin":867,"end":868},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T157","span":{"begin":901,"end":905},"obj":"http://purl.obolibrary.org/obo/UBERON_0000473"},{"id":"T158","span":{"begin":1137,"end":1141},"obj":"http://purl.obolibrary.org/obo/UBERON_0000473"},{"id":"T159","span":{"begin":1458,"end":1462},"obj":"http://purl.obolibrary.org/obo/UBERON_0000473"}],"text":"The lesson we learned from this global experience may be useful to improve nuclear medicine laboratories’ daily activities. Such implementation should have been put into practice as standard protocol rather than only during potential new emergencies. This is the only way to assure high-quality healthcare performances in terms of numbers and therapeutic strategies regardless specific contingencies without sacrificing medical assistance in favor of emergency needs. Protection of healthcare personnel, with personal protective equipment use and strict hand and laboratory hygiene, should be always recommended. To minimize contact, all information regarding the performing test, clinical history data, and consent to undertake the test should be provided prior to the patients’ on-site arrival. On the other hand, patient’s compliance should be always assured with a brief and safe interview before test. Regarding the choice of imaging protocol during the pandemic, this aspect should take into account only the diagnostic and prognostic evidences provided by literature as regards to the maximum benefit of patients from the type of test performed preferring 1-day-pharmacological stress-first SPECT-MPI protocols to optimize not only radioactive dose exposure but also the time of patient staying in hospital facilities. Patient selection for SPECT-MPI should be based on clinical judgment on expected benefit to guide management, on the urgency of the test, and in discussion with the referring clinician."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T22","span":{"begin":83,"end":91},"obj":"Chemical"}],"attributes":[{"id":"A22","pred":"chebi_id","subj":"T22","obj":"http://purl.obolibrary.org/obo/CHEBI_23888"}],"text":"The lesson we learned from this global experience may be useful to improve nuclear medicine laboratories’ daily activities. Such implementation should have been put into practice as standard protocol rather than only during potential new emergencies. This is the only way to assure high-quality healthcare performances in terms of numbers and therapeutic strategies regardless specific contingencies without sacrificing medical assistance in favor of emergency needs. Protection of healthcare personnel, with personal protective equipment use and strict hand and laboratory hygiene, should be always recommended. To minimize contact, all information regarding the performing test, clinical history data, and consent to undertake the test should be provided prior to the patients’ on-site arrival. On the other hand, patient’s compliance should be always assured with a brief and safe interview before test. Regarding the choice of imaging protocol during the pandemic, this aspect should take into account only the diagnostic and prognostic evidences provided by literature as regards to the maximum benefit of patients from the type of test performed preferring 1-day-pharmacological stress-first SPECT-MPI protocols to optimize not only radioactive dose exposure but also the time of patient staying in hospital facilities. Patient selection for SPECT-MPI should be based on clinical judgment on expected benefit to guide management, on the urgency of the test, and in discussion with the referring clinician."}

{"project":"LitCovid-sentences","denotations":[{"id":"T148","span":{"begin":0,"end":123},"obj":"Sentence"},{"id":"T149","span":{"begin":124,"end":250},"obj":"Sentence"},{"id":"T150","span":{"begin":251,"end":467},"obj":"Sentence"},{"id":"T151","span":{"begin":468,"end":612},"obj":"Sentence"},{"id":"T152","span":{"begin":613,"end":796},"obj":"Sentence"},{"id":"T153","span":{"begin":797,"end":906},"obj":"Sentence"},{"id":"T154","span":{"begin":907,"end":1325},"obj":"Sentence"},{"id":"T155","span":{"begin":1326,"end":1511},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"The lesson we learned from this global experience may be useful to improve nuclear medicine laboratories’ daily activities. Such implementation should have been put into practice as standard protocol rather than only during potential new emergencies. This is the only way to assure high-quality healthcare performances in terms of numbers and therapeutic strategies regardless specific contingencies without sacrificing medical assistance in favor of emergency needs. Protection of healthcare personnel, with personal protective equipment use and strict hand and laboratory hygiene, should be always recommended. To minimize contact, all information regarding the performing test, clinical history data, and consent to undertake the test should be provided prior to the patients’ on-site arrival. On the other hand, patient’s compliance should be always assured with a brief and safe interview before test. Regarding the choice of imaging protocol during the pandemic, this aspect should take into account only the diagnostic and prognostic evidences provided by literature as regards to the maximum benefit of patients from the type of test performed preferring 1-day-pharmacological stress-first SPECT-MPI protocols to optimize not only radioactive dose exposure but also the time of patient staying in hospital facilities. Patient selection for SPECT-MPI should be based on clinical judgment on expected benefit to guide management, on the urgency of the test, and in discussion with the referring clinician."}

{"project":"LitCovid-PubTator","denotations":[{"id":"267","span":{"begin":770,"end":778},"obj":"Species"},{"id":"268","span":{"begin":816,"end":823},"obj":"Species"},{"id":"269","span":{"begin":1111,"end":1119},"obj":"Species"},{"id":"270","span":{"begin":1286,"end":1293},"obj":"Species"},{"id":"271","span":{"begin":1326,"end":1333},"obj":"Species"}],"attributes":[{"id":"A267","pred":"tao:has_database_id","subj":"267","obj":"Tax:9606"},{"id":"A268","pred":"tao:has_database_id","subj":"268","obj":"Tax:9606"},{"id":"A269","pred":"tao:has_database_id","subj":"269","obj":"Tax:9606"},{"id":"A270","pred":"tao:has_database_id","subj":"270","obj":"Tax:9606"},{"id":"A271","pred":"tao:has_database_id","subj":"271","obj":"Tax:9606"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"The lesson we learned from this global experience may be useful to improve nuclear medicine laboratories’ daily activities. Such implementation should have been put into practice as standard protocol rather than only during potential new emergencies. This is the only way to assure high-quality healthcare performances in terms of numbers and therapeutic strategies regardless specific contingencies without sacrificing medical assistance in favor of emergency needs. Protection of healthcare personnel, with personal protective equipment use and strict hand and laboratory hygiene, should be always recommended. To minimize contact, all information regarding the performing test, clinical history data, and consent to undertake the test should be provided prior to the patients’ on-site arrival. On the other hand, patient’s compliance should be always assured with a brief and safe interview before test. Regarding the choice of imaging protocol during the pandemic, this aspect should take into account only the diagnostic and prognostic evidences provided by literature as regards to the maximum benefit of patients from the type of test performed preferring 1-day-pharmacological stress-first SPECT-MPI protocols to optimize not only radioactive dose exposure but also the time of patient staying in hospital facilities. Patient selection for SPECT-MPI should be based on clinical judgment on expected benefit to guide management, on the urgency of the test, and in discussion with the referring clinician."}